產(chǎn)品名稱 | FITC標(biāo)記的磷酸化間變型淋巴瘤激酶抗體 |
英文名稱 | Anti-phospho-ALK (Tyr1586)/FITC |
規(guī)格 | 100ul |
濃度 | 1mg/ml |
價(jià)格 | 來(lái)電可享受優(yōu)惠 |
英文名稱 Anti-phospho-ALK (Tyr1586)/FITC
中文名稱 :FITC標(biāo)記的磷酸化間變型淋巴瘤激酶抗體
規(guī)格:100ul
說(shuō)明書 100ul
產(chǎn)品類型磷酸化抗體
研究領(lǐng)域腫瘤 神經(jīng)生物學(xué) 信號(hào)轉(zhuǎn)導(dǎo) 生長(zhǎng)因子和激素 激酶和磷酸酶 通道蛋白
抗體來(lái)源Rabbit
克隆類型Polyclonal
交叉反應(yīng) Human, Mouse, Rat, Chicken, Cow, Horse,
產(chǎn)品應(yīng)用IF=1:50-200
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
分子量174kDa
性 狀Lyophilized or Liquid
濃 度1mg/ml
免疫原KLH conjugated Synthesised phosphopeptide derived from human ALK around the phosphorylation site of Tyr1586
亞 型IgG
純化方法affinity purified by Protein A
儲(chǔ)存液0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
保存條件Store at -20 °C for one year.
別 名 ALK (Phospho-Tyr1586); ALK(phospho-Y1586); p-ALK(Tyr1586); p-ALK(Y1586); ALK tyrosine kinase receptor precursor; ALK/EML4 fusion gene, included; ALK/NPM1 fusion gene, included; anaplastic lymphoma kinase (Ki-1); Anaplastic lymphoma kinase; Anaplastic lymphoma kinase Ki 1; Anaplastic lymphoma kinase Ki1; Anaplastic lymphoma kinase p80 CD 246; CD246; CD246 antigen; EC 2.7.10.1 Ki 1; Ki1; NBLST3; Tcrz; TFG/ALK; ALK_HUMAN.
